Zydelig (Idelalisib) | Named Patient Program

Kamal Kaushal05 May, 2022Health

Zydelig (Idelalisib) is a kinase inhibitor indicated for the treatment of patients with Relapsed chronic lymphocytic leukemia (CLL). Sometimes patients required Zydelig (Idelalisib) medicine but that is not yet permitted or available in the country. Then AlleviareIndia "Named Patient Program" fill the gap by consulting the option available to eligible patients to get access to the Zydelig (Idelalisib) medicine.